|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2007-10-30
|
|
pubmed:abstractText |
Nephrogenic systemic fibrosis may be caused by gadolinium (Gd)-containing magnetic resonance imaging contrast agents. Most reported cases were associated with one particular agent, gadodiamide. Yet, unidentified cofactors might explain why only a minority of renal failure patients exposed to gadodiamide develop nephrogenic systemic fibrosis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0931-0509
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3174-8
|
|
pubmed:meshHeading |
pubmed-meshheading:17483196-Case-Control Studies,
pubmed-meshheading:17483196-Dose-Response Relationship, Drug,
pubmed-meshheading:17483196-Female,
pubmed-meshheading:17483196-Gadolinium,
pubmed-meshheading:17483196-Gadolinium DTPA,
pubmed-meshheading:17483196-Humans,
pubmed-meshheading:17483196-Kidney Diseases,
pubmed-meshheading:17483196-Kidney Failure, Chronic,
pubmed-meshheading:17483196-Male,
pubmed-meshheading:17483196-Middle Aged,
pubmed-meshheading:17483196-Reference Values
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Case-control study of gadodiamide-related nephrogenic systemic fibrosis.
|
|
pubmed:affiliation |
Department of Nephrology, Herlev Hospital, DK-2730 Herlev, Denmark. peter.marckmann@dadlnet.dk
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
